Faulty CAPA Handling Brings Warning Letter to Mindray

The GMP Letter
A A
Mindray DS USA, a unit of Chinese device giant Mindray, received an FDA warning letter for faulty handling of corrective and preventive actions (CAPA).

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $135.00